Healthcare platform Sesame announced a new weight loss program offering compounded versions of Novo Nordisk A/S's (NYSE:NVO) blockbuster drug Wegovy for $249 per month. The program aims to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results